We are transitioning from basic PPG sensors to multi-spectral optical arrays and interstitial fluid monitors. Our custom OEM solutions now integrate EDA (Electrodermal Activity) and bio-impedance sensors to provide a holistic view of metabolic health and autonomic nervous system stress.
The future of Health Risk Assessment (HRA) lies in reducing latency. By deploying TinyML models directly on the wearable firmware, our devices can detect early signs of atrial fibrillation or respiratory distress without relying on cloud processing, ensuring user privacy and instant alerts.
Integration with FHIR and HL7 standards is no longer optional. Our manufacturing protocols ensure that every wearable device serves as a data node within the broader hospital management system, facilitating Decentralized Clinical Trials (DCTs) and remote patient monitoring.
The global shift towards value-based care has placed Wearable Health Risk Assessment Devices at the center of medical innovation. As a leading manufacturer, we address the specific pain points of diverse healthcare stakeholders.
Supporting CROs with medical-grade data accuracy. Our devices offer 99.9% uptime for continuous monitoring, vital for high-stakes drug efficacy studies.
Customized white-label platforms that predict employee burnout and cardiovascular risks through advanced HRV analysis and sleep architecture tracking.
Implementing fall detection and geofencing protocols integrated with real-time biometric risk scoring to provide a safety net for aging populations.
Dynamic underwriting through actuarial data streams. Devices provide verified health metrics that allow for personalized premium adjustments.
Square Meters Facility
Expert Technicians
Medical OEM Experience
Certified Quality Control
Located in the heart of Dongguan, China’s silicon valley for medical hardware, Dongguan Trial Medical Co., Ltd. leverages a world-class supply chain ecosystem. We provide Supply Chain Resilience by maintaining vertical integration—from PCB assembly and sensor calibration to final cleanroom packaging. This allows us to reduce lead times by 30% compared to international competitors while maintaining rigorous CE and FDA-aligned quality standards.
Our Factory 4.0 initiative incorporates automated optical inspection (AOI) and AI-driven quality assurance, ensuring that every wearable health risk device leaving our floor is calibrated for clinical-grade precision.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
Supported by an experienced team of engineers, software developers, and quality management professionals, Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies. The company integrates advanced connectivity technologies, cloud-based data management capabilities, and intelligent monitoring functions to support reliable and scalable clinical research operations.
Comprehensive quality control procedures are implemented across product design, manufacturing, testing, and inspection processes to ensure consistent performance and product reliability. In addition to its standard product offerings, the company provides OEM and ODM services tailored to specific research applications and market requirements.
Serving customers across North America, Europe, Asia-Pacific, the Middle East, Latin America, and Africa, Dongguan Trial Medical Co., Ltd. is committed to advancing digital clinical research through innovative technologies that support decentralized studies, patient-centric trial models, and data-driven healthcare innovation worldwide.
We navigate the complex landscape of FDA Class II, CE MDR, and NMPA certifications. Our documentation is ready for your submission, significantly reducing your time-to-market.
Compliance with GDPR (Europe), HIPAA (USA), and PIPL (China) is hardcoded into our software architecture, ensuring biometric data sovereignty for global users.
We offer flexible MoQ (Minimum Order Quantities) and multi-currency billing, designed to support both agile startups and Fortune 500 pharmaceutical giants.
We use medical-grade PPG and ECG sensors validated against gold-standard clinical equipment. Our proprietary algorithms undergo rigorous testing in decentralized trial environments to ensure data reliability (E-E-A-T principle).
Yes, our R&D team specializes in custom OEM/ODM services. We can modify sampling rates, integrate specific biometric indicators, and develop bespoke encryption protocols tailored to your study's needs.
For standard configurations, lead time is 4-6 weeks. For highly customized hardware involving new mold development, it ranges from 12-16 weeks, supported by our robust Supply Chain 4.0 infrastructure.
By providing "Information Gain"—unique data insights like vascular age estimation and cumulative stress indexing—our devices offer more than just raw data; they provide actionable health intelligence for preventive care.
Absolutely. Our devices utilize 5G and low-energy Bluetooth (BLE) to sync with our proprietary cloud platform or your own API, enabling real-time remote patient monitoring and intervention.
Trial Medical
